Paul Tudor Jones Rocket Pharmaceuticals, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 16,787 shares of RCKT stock, worth $165,519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,787Holding current value
$165,519% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding RCKT
# of Institutions
226Shares Held
96.6MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$174 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$138 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$64.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$61.1 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$46.5 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $746M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...